XTX Topco’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.29M Buy
93,609
+83,775
+852% +$4.88M 0.09% 260
2025
Q4
$584K Sell
9,834
-10,433
-51% -$568K 0.02% 1464
2025
Q3
$1.1M Buy
+20,267
New +$1.16M 0.06% 520
2025
Q1
Sell
-18,010
Closed -$1.18M 2440
2024
Q4
$1.18M Buy
18,010
+11,112
+161% +$744K 0.1% 213
2024
Q3
$485K Buy
6,898
+1,880
+37% +$157K 0.04% 841
2024
Q2
$413K Sell
5,018
-6,121
-55% -$510K 0.04% 753
2024
Q1
$973K Buy
11,139
+9,029
+428% +$808K 0.13% 170
2023
Q4
$203K Sell
2,110
-7,631
-78% -$675K 0.04% 950
2023
Q3
$862K Sell
9,741
-6,339
-39% -$564K 0.15% 146
2023
Q2
$1.39M Buy
+16,080
New +$1.51M 0.25% 41
2023
Q1
Sell
-3,484
Closed -$361K 1284
2022
Q4
$361K Buy
+3,484
New +$327K 0.08% 464
2022
Q3
Sell
-4,038
Closed -$335K 1109
2022
Q2
$335K Sell
4,038
-3,756
-48% -$299K 0.14% 233
2022
Q1
$601K Buy
7,794
+4,771
+158% +$399K 0.26% 105
2021
Q4
$267K Buy
+3,023
New +$249K 0.15% 243
2021
Q2
Sell
-6,947
Closed -$525K 823
2021
Q1
$525K Buy
+6,947
New +$567K 0.26% 84

Other funds holding BMRN